Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 4/20 | 0.56 |
| ▸ | CHRNA7 | P36544 | 9/20 | 0.55 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.48 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.46 |
| ▸ | CTSL | P07711 | 1/20 | 0.46 |
| ▸ | CTSB | P07858 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23965858 | 0.81 | TYR (0.53) | TYRCHRNA7CYP19A1CAPN1CTSL | |
| SCHEMBL675094 | 0.74 | TYR (1.00) | TYRCHRNA7CYP19A1CAPN1CTSL | |
| SCHEMBL675095 | 0.74 | TYR (1.00) | TYRCHRNA7CYP19A1CAPN1CTSL | |
| SCHEMBL19236264 | 0.73 | CHRNA7 (1.00) | TYRCHRNA7 | |
| SCHEMBL9175439 | 0.69 | TYR (0.77) | TYRCHRNA7CYP19A1CAPN1CTSL | |
| SCHEMBL9175445 | 0.69 | TYR (0.77) | TYRCHRNA7CYP19A1CAPN1CTSL | |
| SCHEMBL14696923 | 0.68 | CHRNA7 (0.75) | TYRCHRNA7CAPN1CTSLCTSB | |
| SCHEMBL14696922 | 0.68 | CHRNA7 (0.75) | TYRCHRNA7CAPN1CTSLCTSB | |
| SCHEMBL2977785 | 0.68 | CHRNA7 (1.00) | TYRCHRNA7CAPN1CTSLCTSB | |
| SCHEMBL2977786 | 0.68 | CHRNA7 (1.00) | TYRCHRNA7CAPN1CTSLCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210332022-A1 | DIHYDROFURAN CHALCONE COMPOUND AND PREPARATION METHOD THEREOF | SOUTH CHINA BOTANICAL GARDEN, CHINESE ACADEMY OF SCIENCES (CN) | 2021-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210332022-A1 | DIHYDROFURAN CHALCONE COMPOUND AND PREPARATION METHOD THEREOF | SORD, HPSE, NUDC | TYR 2919/4885CHRNA7 4183/4885CYP19A1 827/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.